Collaboration between government agencies, academia, and the private sector is the key to combating pathogen resistance and finding new ways to prevent, diagnose, and treat bacterial infections, according to a recently released action plan from the Centers for Disease Control and Prevention (www.cdc.gov/drugresistance/). The plan, developed by an intergovernmental task force headed by the National Institutes of Health, CDC, and Food and Drug Administration, outlines four major areas important to combating resistance: surveillance, prevention and control, product development, and research. "We saw the need for maximum communication among a broad range of entities involved in antimicrobial resistance research. This interaction is helpful in defining roles and responsibilities, concentrating our efforts of maximum efficiency, and avoiding unnecessary redundancy," says Dennis M. Dixon, co-chair of the task force and chief of the bacteriology and mycology branch at National Institutes of Health. "The plan offers a way to address antimicrobial resistance." The research ...
News Notes
Government Organizes Against Pathogen Resistance Collaboration between government agencies, academia, and the private sector is the key to combating pathogen resistance and finding new ways to prevent, diagnose, and treat bacterial infections, according to a recently released action plan from the Centers for Disease Control and Prevention (www.cdc.gov/drugresistance/). The plan, developed by an intergovernmental task force headed by the National Institutes of Health, CDC, and Food and Drug Admi
Written byJennifer Fisher Wilson
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
